F-STAR THERAPEUTICS INC's ticker is FSTX and the CUSIP is 30315R107. A total of 55 filers reported holding F-STAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $334,966 | +23.6% | 53,001 | 0.0% | 0.23% | +14.6% |
| Q3 2022 | $271,000 | -18.4% | 53,001 | 0.0% | 0.20% | -11.9% |
| Q2 2022 | $332,000 | +76.6% | 53,001 | 0.0% | 0.23% | +105.5% |
| Q1 2022 | $188,000 | -29.3% | 53,001 | 0.0% | 0.11% | -26.2% |
| Q4 2021 | $266,000 | -31.4% | 53,001 | 0.0% | 0.15% | -53.3% |
| Q3 2021 | $388,000 | -14.7% | 53,001 | 0.0% | 0.32% | -14.2% |
| Q2 2021 | $455,000 | -20.7% | 53,001 | 0.0% | 0.37% | -27.1% |
| Q1 2021 | $574,000 | +9.8% | 53,001 | 0.0% | 0.51% | +6.7% |
| Q4 2020 | $523,000 | – | 53,001 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 54,298 | $343 | 1.69% |
| Trium Capital LLP | 679,744 | $4,296 | 1.58% |
| Vazirani Asset Management LLC | 125,000 | $790 | 1.34% |
| Atlas Venture Advisors, Inc. | 574,996 | $3,633,975 | 1.25% |
| Crystalline Management Inc. | 375,000 | $2,370,000 | 1.19% |
| DAFNA Capital Management LLC | 576,881 | $3,645,888 | 1.03% |
| BCK CAPITAL MANAGEMENT LP | 137,459 | $868,741 | 0.89% |
| Atlas Venture Life Science Advisors, LLC | 599,524 | $3,788,992 | 0.46% |
| Ridgeback Capital Investments L.P. | 52,509 | $331,857 | 0.40% |
| Connolly Sarah T. | 53,001 | $334,966 | 0.23% |